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  Drugs used in the chemotherapy of cancer have also been used as immuno-
suppressive agents for the control of immune mechanisms involving antibody
production, and cell-mediated forms of immunity such as delayed-type hyper-
sensitivity and transplantation immunity (1-5) ; there are, however, few pub-
lished reports of their effect on the immune response to microorganisms despite
infection being a serious complication of their use in clinical practice. The
present report deals with the influence of some immunosuppressive drugs on
the immune response to a facultative intracellular parasite.
Tuberculosis, brucellosis, listeriosis, and salmonellosis are examples of infec-
tions which give rise to a cell-mediated form of immunity which evolves through
similar mechanisms (6) ; it is therefore logical to assume that observations on
one host-parasite system will have relevance to the others. Listeriosis in the
mouse has been chosen as a model for the present study because it offers several
advantages. Firstly, the immune response sets in early and runs a short course,
so that an immunosuppressive effect is quickly revealed; secondly, a Listeria
infection, as assessed by bacterial enumeration, provides an accurate and
quantitative assessment of immunity and the magnitude of the immunosup-
pressive effect obtained with drugs. Mice infected with a sublethal dose of
Listeria monocytogenes d velop an immune response which interrupts the growth
of the organism in vivo. The experiments to be described are based upon the
premise that effective suppression of the immune response by drugs would result
in continued multiplication of Listeria, particularly in the spleen and liver.
Four drugs, representing four different categories of cytotoxic agents, were
chosen for study: (a) cyclophosphamide, a polyfunctional alkylating agent;
(b) vinblastine, an antimitotic agent; (c) methotrexate, a folic acid antagonist;
and (d) azathioprine, a purine analogue. The present report deals with the effect
of these four drugs on the immune response to Listeria infection in mice.
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Materials and Methods
Mice.– Female specific pathogen-free (SPF)mice derived from COBS progenitors were
used. The mice were about 5-7 wk old and usually weighed between 18 and 22 g at the time of
infection.
Infecting Strain.– Listeria monocytogenes, strain EGD, was used. This strain has been main-
tained in this laboratory by alternate passage in the mouse spleen and trypticase soy broth
(TSB) medium. It has remained in the smooth phase and has an intravenous L D50 of appr xi-
mately 5 X 103 viable units. Growth was unaffected by 100 µg/ml of cyclophosphamide, vin-
blastine, methotrexate, or asathioprine when the strain was exposed to these drugs in TSB
medium in vitro.
Infection.– The bacterial content in a logarithmic phase culture of L. mon cytogenes was
determined by direct count (Petroff-Hausser). It was appropriately diluted in Hanks’ Bal-
anced Salt Solution to contain the desired number of bacteria in 0.2 ml, the volume used to
infect animals by intraveous injection. A viable count of the inoculum suspension was invari-
ably made by plating appropriate dilutions of the suspension on trypticase soy agar (TSA)
medium.
Bacterial Enumeration in Liver and Spleen.– Autopsies were conducted on five mice from
each group at each time-point. Five mice were killed 10 min after injection to establish the
initial bacterial content in spleens and livers; thereafter bacterial counts were made at intervals
on five mice from each group at each time-point.
The mice were killed by cervical dislocation. Organs were removed aseptically to ho-
mogenizer tubes containing 8 ml (for liver) or 9 ml (for spleen) of TSB medium, giving final
volumes of approximately 10 ml. They were dispersed for 1 min with a Teflon homogenizer.
Appropriate serial dilutions of each homogenate were then plated on TSA medium. The viable
bacterial content of the viscera was estimated from colony counts after overnight incubation
at 37°C. The geometric means of the viable counts of Listeria in the livers and spleens were
calculated separately for each group. All the results have been presented in this report as mean
viable counts expressed on a logarithmic scale.
Drug Treatment.– MTX1 (Lederle Laboratories, Division of American Cyanamid Co., Pearl
River N. Y.), CY1 (Cytoxan, Mead Johnson & Co., Evansville, Ind., and AZT1 (Imuran, gen-
erously supplied by Burroughs Wellcome & Co., Tuckahoe, N. Y.) were administered subcutane-
ously as aqueous solutions in 0.25 ml containing doses equivalent to 50, 200, and 200 mg/kg body
weight, respectively. VLB1 (vincaleucoblastine sulfate, Velban, Eli Lilly and Co., Indiana-
polis, Ind.) was administered intravenously in a dose of 4 mg/kg, contained in 0.1 ml. Unless
otherwise specified, all drugs were given as single dose treatments, administered on the day
specified. The dosages selected represent the maximum tolerated dose for each drug, based on
observations of Berenbaum and Brown (7) for cyclophosphamide and vinblastine and our own
unpublished observations on all four drugs.
RESULTS
Listeria Growth Pattern in Normal Mice.–
A preliminary study was undertaken to determine the most suitable infecting dose of Listeria
monocytogenes. Four groups of mice were infected with varying doses of L. mon cytogenes.
Viable counts were performed at frequent intervals thereafter, as recorded in Fig. 1.
The course of infection in the liver was similar in all four groups during the
first 24 hr. Beyond that time, the shape of the growth curve was dependent upon
1 MTX, methotrexate; CY, cyclophosphamide; AZT, azathioprine; VLB, vinblastine.
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the infecting dose. All groups showed an initial fall, ranging from 30-81% at
3 hr; thereafter, there was a steady and parallel rise during the next 21 hr.
Between 24 and 48 hr, bacterial growth continued unchecked only in the ani-
mals infected with the largest dose of organisms; all others showed an inflec-
tion which was interpreted as evidence of an immune response on the part of
the host tending to limit further multiplication of the organisms.
The spleen counts showed no evidence of an initial fall; growth continued
log-linearly in the spleen for only 12 hr. Thereafter, there was a change in the
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FIG. 1. Growth curves of L. monocytogenes in livers and spleens of mice infected at varying
dose levels. Each plot represents the mean from five mice.
slope, most marked at lower dose levels. Although the growth curve indicates
some inhibition with the largest infecting dose, the effect is spurious since it
results from the inability of a necrotic spleen to support a bacterial population
much larger than 108 Listeria.
It is apparent that the effect of developing resistance is most obvious in both
liver and spleen with a low infecting dose of organisms. For this reason the
effect of immunosuppressive drugs was studied in animals infected with less
than 104 bacteria.
The Course of Injection in Mice Treated with a Single Dose of Drug on the
Day of  Infect ion.–
Three groups of mice infected with 2 X 1 03 Listeria were treated with single injections of
cyclophosphamide, vinblastine, and methotrexate; the course of infection in the three groups
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was plotted daily, using five mice from each group at each time-point. The growth curves were
compared with those in control mice which received no treatment. The results are recorded in
Fig. 2.
The liver counts indicated that untreated mice exhibited an immune response
resulting in effective control of bacterial multiplication beyond 24 hr. In
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F IG . 2. Growth curves of L. monocytogenes in the livers and spleens of untreated mice
(control) and mice given a single dose of cyclophosphamide (CY), vinblastine (VLB), or
methotrexate (MTX) on the day of infection. All remaining mice in groups VLB and CY died
between days 3 and 4.
contrast, the immune response was effectively suppressed in the three drug-
treated groups, as evidenced by continued bacterial growth. In comparison
with the controls, bacterial counts at 48 hr were significantly higher for cyclo-
phosphamide (P < 0.05), vinblastine (P < 0.01), and methotrexate (P <
0.05). The bacterial content continued to increase between 48 and 72 hr in
cyclophosphamide- and vinblastine-treated mice, resulting in the death of all
remaining mice between 3 and 4 days.
The effects of methotrexate were markedly different from those of cyclo-
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phosphamide and vinblastine. Its immunosuppressive effect persisted for only
48 hr, as is evidenced by the shape of the curve beyond that time. This suggests
that the immunosuppressive effect of methotrexate, in contrast to that of
cyclophosphamide or vinblastine, is reversible.
The course of infection in the spleen presented broadly similar features
except that the magnitude of the differences between the bacterial populations
in the drug-treated and the control groups was smaller.
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FIG. 3. Growth curves of L. monocytogenes in control mice and mice treated with a single
injection of azathioprine (AZT) at the time of infection.
In a similar experiment, the influence of azathioprine was studied. The
results, presented in Fig. 3, showed that azathioprine completely suppressed the
immune response; the differences between the control and the drug-treated
groups at 72 and 96 hr attained significance (P <0.05 and <0.01, respectively).
Effect of Repeated Administration of Methotrexate on the Course of Injection.–
The transient nature of the immunosuppression achieved with a single injection
of methotrexate on the day of infection prompted a study to determine whether
an immunosuppressive effect could be sustained by the administration of a
second injection of MTX at 24 hr. The results, presented in Fig. 4, showed that
complete suppression of immunity was achieved only in animals which received
a second injection of methotrexate.
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FIG. 4. Growth curves of L. monocytogenes showing the effects of a single dose of metho-
trexate given at the time of infection (MTX-1); and of two doses given at infection and 24 hr
later (MTX-2).
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Time-Response Relationship.– It has been shown that a single dose of drug
administered at the time of infection effectively suppressed the immune response
to a Listeria infection. It was of interest to study next the immunosuppressive
effects produced with a single dose administered at varying times before and
after the initiation of infection.
The results of treatment with cyclophosphamide administered before or after
the initiation of infection are contained in Figs. 5 and 6. They show that the
drug produced conspicuous impairment of the immune response when given as
early as 48 hr before infection (Fig. 5). It was also capable of interfering with
an ongoing response, as indicated by the curves obtained in animals treated 24
or 48 hr after infection (Fig. 6).
The data presented in Figs 5 and 6 can be used to express drug effects in
terms of an immunosuppressive index; i.e., the difference between the log viable
counts in drug-treated and control groups at any time. Since drug-treated
animals do not always survive beyond 3 days of drug-host-parasite interaction,
the bacterial counts at 72 hr were chosen for expressing the immunosuppressive
index in the following studies with cyclophosphamide, vinblastine, and metho-
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trexate. The experimental plan was similar to that used in the previous experi-
ment.
Using the immunosuppressive index as defined above, the degree of immuno-
suppression obtained with a single injection of cyclophosphamide, vinblastine,
and methotrexate administered at periods ranging from 11 days before to 7 days
- 1
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F IG . 7. Plots showing the differences in the immunosuppressive indices obtained in the
liver when single doses of cyclophosphamide (CY), vinblastine (VLB), or methotrexate (MTX)
were administered at varying times before (– 11 to –1 days) or during (0 to +7 days) a
Listeria infection.
after the initiation of infection was measured. The results are presented in Figs.
7 and 8. Considering first the effects observed in the liver, it is apparent that
cyclophosphamide was immunosuppressive over a broad interval of time, from
-2 to +4 days, its influence being virtually maximal during this period. Vin-
blastine, on the other hand, produced its greatest effect when given at the time
of infection. It had only a slight influence when given prior to infection but was
very active when given during the first 48 hr after infection. In the case of
methotrexate, maximum activity was achieved in animals treated 48 hr after.
An interesting feature of the curves shown in Fig. 7 was the negative immuno-
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suppressive index observed in animals treated with cyclophosphamide and
vinblastine 7-11 days before infection, and a similar effect with methotrexate
given 4 days before infection. This immunity-enhancing influence of immuno-
suppressive drugs when given prior to an immunological stimulus has been
observed in other systems and will be discussed in greater detail later.
The immunosuppressive indices in the spleen (Fig. 8) were broadly similar
but showed a tendency for the curves to shift to the right.
+ 5
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F IG. 8. Plots showing the differences in the immunosuppressive indices obtained in the
spleen when single doses of cyclophosphamide (CY),vinblastine (VLB), or methotrexate
(MTX) were administered at varying times before (– 11 to – 1 days) or during (0 to +7 days)
a Listeria infection.
DISCUSSION
M a n y  cytotoxic agents owe their immunosuppressive activity to their
capacity to attack rapidly proliferating cells. Their action on humoral antibody
production (l-4) or cell-mediated forms of immunity such as delayed-type
hypersensitivity (5)and transplantation immunity (8, 9), have provided valu-
able information concerning the cellular events associated with these types of
immune response. There have, however, been few studies concerned with their
effect upon acquired resistance to infectious diseases, even though infection
represents the major hazard associated with the use of such agents.
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Our investigations have shown that administration of a single dose of any
one of four broadly representative cytotoxic agents has profound effects on the
course of Listeria infection in mice. It is of interest to consider what known ef-
fects of these cytotoxic agents could be heldresponsible for the results obtained.
Since infection with intracellular parasites results in a cell-mediated form of im-
munity (10, 11), it is appropriate to discuss them in relation to reported findings
of their action on delayed-type hypersensitivity and transplantation immunity.
The ultimate expression of resistance against intracellular bacterial parasites
rests with the macrophage and not with the lymphoid cells which mediate the
mechanism of immunity (10, 11). It is therefore possible that some of the effects
observed might be due to interference with the activities of macrophages. That
this is not a major factor is evidenced by findings, to be reported later,2 which
show that animals immunized with a heterologous organism (BCG) retain their
resistance to challenge with L. monocytogenes after treatment with cyclophos-
phamide, vinblastine, or methotrexate. Since this nonspecific resistance is
known to be due to activated macrophages, it is reasonable to conclude that
none of these drugs has any major influence on the functional activity of macro-
phages. Moreover, 6-mercaptopurine, a purine analogue similar to azathioprine,
does not influence the rate of clearance of heterologous erythrocytes from blood
(12), nor does nitrogen mustard (believed by some to be the active form of
cyclophosphamide) affect the particle clearing function of the reticuloendo-
thelial system (13). These observations again indicate a lack of direct toxicity
for the macrophage. It would appear therefore that most of the effects observed
in the present study can be attributed to the influence of the drugs on the lym-
phoid cells which become engaged in the immune response leading to acquired
resistance. More persuasive evidence on this point is presented in an accom-
panying paper (28).
There are at least three ways of interfering with an immune response: (a )
depletion of immunocompetent cells by direct cytolysis; (b) impairment of cell
metabolism; and (c) selective destruction, with mitotic poisons, of those cells
which divide in the course of the immune response. The results obtained with
the four drugs will be discussed in relation to these three possible modes of
action.
The exact mechanism of induction of cellular immunity in listeriosis is as yet
ill-defined. Present evidence indicates that it may be similar to the induction of
delayed-type hypersensitivity (10, 11). Turk (5) has proposed that the steps
leading to this type of hypersensitivity involve the sequence: small lymphocyte
–› immunoblast –›) immunologically committed small lymphocytes. That the
immune mechanism in listeriosis is mediated through the lymphoid series of
2 Mackaness, G. B., and S. P. Tripathy. 1969. The effect of cytotoxic agents on established
resistance to Listeria monocytogenes. Manuscript in preparation.
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cells and not by serum antibody, is indicated by recent studies from this labora-
tory which show that lymphoid cells from Listeria- immune mice are capable of
conferring absolute immunity to Lis eria challenge when transferred to normal
recipients (10); and that specific antilymphocyte globulin abolishes the protec-
tion conferred in this way (11). The occurrence of pyroninophilic cells (similar
to the pyroninophilic “immunoblasts” of Turk) in the spleens of mice during
the early stages of infection3 indicates that the evolution of the immune lym-
phoid cells in listeriosis could well involve the sequential stages: precursor cell
–› immunoblast –› immunologically committed small lymphocytes. It is clear
that immunosuppressive drugs could act on any of these three cell populations.
Cyclophosphamide, a member of the mustard series, belongs to a class of
drugs designated as polyfunctional alkylating agents which have been shown to
exert their toxic action on cells by forming crosslinks between double-stranded
DNA, interfering with transcription and replication (14). Studies with ascites
tumor cells have shown that the drug acts on the premitotic resting phase (G2),
as well as on the DNA-synthetic phase (S) of the cell cycle (15); it is toxic to
precursor cells of both the erythroid and the lymphoid series (16). Nitrogen
mustard (and presumably cyclophosphamide) is directly lethal for lymphocytes
(17). It would seem therefore that cyclophosphamide has the potential to
damage lymphoid cells at all stages of the immune response. Turk’s investiga-
tions on delayed-type hypersensitivity suggest that it acts in three ways: it
prevents the differentiation of small lymphocytes to immunoblasts; has a direct
toxic action on immunoblasts; and is antimitotic. Our observations are con-
sistent with this view since cyclophosphamide was found to have a profound
effect on the host’s resistance when given at any time from 2 days before to 4
days after infection, suggesting that it can affect the precursor cell, the
intermediate cell, and possibly the immunologically committed small lympho-
cyte.
Vinblastine sulphate is known to act on dividing cells (18) ; it prevents the
formation of the mitotic spindle, causing arrest in metaphase. Its effects are be-
lieved to be irreversible so that arrested cells ultimately die. The immunosup-
pressive effects obtained with vinblastine in the present study are therefore a
reflection of the mitotic activity occurring during a normal immune response
and thus throw some light on the cellular events which occur during the initial
stages of the host’s immune response to L. monocytogenes.
The slope of the normal growth curve from 12 to 24 hr (Fig. 1) indicates that
the host’s immune response is already manifest in the spleen at 24 hr. Radio-
autographic studies on spleens of Li teria- infected mice show marked mitotic
activity at this time.3 A relationship between this mitotic response and the de-
3 North, R. J. 1969. Cellular kinetics associated with the development of acquired cellular
resistance. Submitted for publication.
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velopment of immunity is indicated by the immunosuppressive effect obtained
with a single dose of vinblastine administered at th  time of infection. In fact,
vinblastine was most effective when given at this time, suggesting that the
presence of vinblastine for 15-18 hr (the duration of effective serum levels of
vinblastine with the dosage employed) results in the deletion of all cells which
have become mitotically engaged as a result of the immune response. This would
interfere drastically with the natural transition from the precursor cell to im-
munologically committed small lymphocyte, and hold the host’s acquired de-
fenses in abeyance.
Azathioprine and methotrexate are antimetabolites which specifically inter-
fere with the processes leading to the synthesis of DNA. Azathioprine prevents
the conversion of inosinic acid to adenylic acid, an essential step in the synthesis
of nucleic acids; it may, in addition, act through binding of sulfhydryl groups
(1). Since a single dose of azathioprine, given at the time of infection, effectively
suppresses the immune response (Fig. 3), its effects would seem to be irrever-
sible in contrast to those of methotrexate (Fig. 2).
The most important biochemical lesion caused by methotrexate is a result of
its profound influence on folic reductase. This enzyme reduces folic acid to di-
hydrofolic acid and tetrahydrofolic acid, thereby interfering with the formation
of thymidine (19). The drug is believed to be bound irreversibly to the enzyme
so that methotrexate treatment results in thymidine deficiency and impairment
of DNA synthesis.
The present studies showed two features which distinguish the effect of
methotrexate from those produced by other drugs. The time-response relation-
ship showed that the immunosuppressive activity of methotrexate was highest
when the drug was administered at 48 hr after infection, indicating that the drug
probably acts most effectively at a later stage of the immune response. Turk (5)
suggested from morphologic studies that methotrexate acts principally on the
transformation of immunoblasts to immunologically committed small lympho-
cytes. North’s studies3 indicate that the maximum mitotic activity (predomini-
nantly involving immunoblasts) is found in the spleens at 48 hr after Liste i
infection. If Turk’s conclusions are applicable to the present model, it would be
at this time that methotrexate would exert its greatest effect in suppressing the
immune response to Listeria, a premise which is borne out by the findings; it is
not clear, however, whether the immunosuppressive effect is due to interference
with further cell division, cell differentiation, or both.
Another feature of interest was the reversible nature of immunosuppression
with methotrexate. Since many tissues have reserves of tetrahydrofolic acid, the
end-product of folic reductase activity, it is possible that after a single dose of
methotrexate the reserves of tetrahydrofolate may be adequate to tide over the
toxic effect of methotrexate toxicity. Under these conditions it is possible that
there may be impairment of cell-function without death, and recovery may
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ensue. It is also possible that the reversible nature of the immunosuppressive
activity may be due to the persistence of some lymphoid cells with greatly ele-
vated levels of folic reductase, a situation which has been encountered in some
tumor cells which survive chemotherapy with methotrexate (20-22). The total
immunosuppression achieved with two doses of methotrexate, while in favor of
the former, suggests that the latter explanation is unlikely. The results thus
indicate that cells can escape from the lethal action of this drug unless its levels
are sustained.
The transient nature of methotrexate activity is also seen with other immune
systems. Friedman and Buckler (23) observed that while methotrexate sup-
pressed the induction of delayed-type hypersensitivity to tuberculin in guinea
pigs, lymph node cells from these animals were capable of transferring sen-
sitivity to normal recipients 2 wk later. The authors interpreted this finding to
mean that methotrexate prevents the multiplication of sensitized cells but does
not interfere with the induction of the immune response. The results of the
present study give strong support to this view. Fig. 2 shows that bacterial
populations in animals treated with methotrexate had reached levels higher
than 10 million without any overt evidence of an immune response on the part
of the host. Since this number of organisms is invariably lethal to mice ( L D5O
5 X 1 03), yet the methotrexate-treated animals effectively controlled them
from the 2nd day onwards, it seems that the immune response had proceeded
in the presence of methotrexate to the extent that cells had been primed during
the early stages; on being released from the effect of methotrexate, the primed
cells must have undergone a sudden burst of activity, resulting in an effective
immune response.
In the present study, pretreatment with three immunosuppressive drugs
4-7 days before infection actually resulted in enhancement of immunity.
Similar effects on antibody production have been produced with cyclophospha-
mide (24), 6-mercaptopurine (6-MP) (25),and cytosine arabinoside (26).
Chanmougan and Schwartz (25) observed that rabbits which had been treated
with 6-MP and rested for 1 wk before challenged with small doses of antigen,
produced levels of circulating antibody considerably higher than were achieved
by untreated animals, an effect attributed to hyperplasia of the lymphoid sys-
tem in the pretreated rabbits (27). Incidental observations in the present study
also indicated that mice which have been treated with cyclophosphamide,
vinblastine, or methotrexate show marked shrinkage of the spleen followed by
gross enlargement and hyperplasia which was manifest 4 days after treatment
with methotrexate and by the 7th day in animals treated with cyclophospha-
mide or vinblastine. Since the phase of hyperplasia coincided with the im-
munity-enhancing effect of the drugs, lymphoid hyperplasia may indeed explain
this paradoxical effect of drugs which are normally immunosuppressive in their
action. If these observations have any relevance to man, inadequate medication
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during immunosuppressive therapy may actually enhance immunologic reac-
tivity with possible adverse consequences. There is therefore a need for a precise
knowledge of the time-dose relationship of each drug for ensuring optimal im-
munosuppressive effects.
The drugs used in the present study are among the most widely used in the
chemotherapy of human cancer, and all but vinblastine are also used as im-
munosuppressive agents for the prevention of graft rejection and the control of
autoimmune diseases. Since they were all found to interfere conspicuously with
the development of resistance to a Listeria infection, it is not surprising that
infection represents a major hazard in their clinical use. But the study has also
shown that an experimental infection can be a very useful model with which to
assess the immunosuppressive activity of drugs and the time-course of their
action.
Analogies exist between the rapid proliferation of cancer cells and that asso-
ciated with the inductive phases of an immune response. It is therefore logical to
assume that drugs which will inhibit cancer cells may have a similar influence on
the host response to infection, as was found in the case of the four anticancer
agents used in this study. The method may perhaps be employed with ad-
vantage in the screening of anticancer agents, since the techniques are simple,
objective, and quantitative.
SUMMARY
Four drugs, representing four different categories of cytotoxic agents, were
studied for their effect on the immune response to Listeria infection in mice.
The development of the host’s immune response is revealed by a progressive
change in the slope of the bacterial growth curve in spleen and liver. It has its
onset at 24 hr in untreated mice, but in the presence of effective immuno-
suppression the organism multiples uninterruptedly until the animal dies
from overwhelming infection. When administered as single injections at the
time of infection, cyclophosphamide, vinblastine, and azathioprine all pro-
duced an effective immunosuppression, characterized by continuous bacte-
rial multiplication.
Methotrexate was also immunosuppressive, but unlike the others its effects
were reversible. They could be sustained, however, by further treatment.
Studies of the time-response relationship indicated that cyclophosphamide
was highly active over a broad time-span ranging from 2 days before infection to
4 days after infection. Vinblastine on the other hand was maximally active when
given on the day of infection, while methotrexate had its greatest effect when
given 48 hr after infection. These differences indicate that these three drugs act
on different cell populations involved in the host’s immune response. The effects
observed have been discussed in relation to what is known of the modes of action
of the drugs tested.
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An observation of interest was the phenomenon of enhanced immunity in
animals treated with cyclophosphamide or vinblastine 7-11 days before, and
with methotrexate 4 days before infection; reactive hyperplasia of lymphoid
tissue following withdrawal of drug was again advanced as an explanation for
the occurrence of this paradoxical effect.
The experimental model employed is simple, requiring only routine bacterio-
logical facilities and minimal equipment. It seems to offer a useful means of
assessing the immunosuppressive activity of drugs and of determining the time-
course of their action; it could also be of value in the screening of anticancer
agents.
The technical assistance of Mr. Jonathan Deissler is gratefully acknowledged.
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